Table 2.
Criterion no. | Criteria |
---|---|
1 | Abrupt onset of painful erythematous plaques or nodules |
2 | Histopathologic evidence of a dense neutrophilic infiltrate without evidence of leukocytoclastic vasculitis |
3 | Pyrexia > 38 °C |
4 | Temporal relationship between drug ingestion and clinical presentation or temporally related recurrence after oral challenge |
5 | Temporally related resolution of lesions after drug withdrawal or treatment with systemic corticosteroids |